recurrent adrenal cortex carcinoma
Showing 1 - 3 of 3
Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,
Active, not recruiting
- Adrenal Cortex Carcinoma
- +39 more
- Cabozantinib
- +2 more
-
Birmingham, Alabama
- +142 more
May 24, 2022
Metastatic Carcinoma in the Adrenal Cortex, Recurrent Adrenal Cortex Carcinoma, Stage III Adrenal Cortex Carcinoma Trial in
Terminated
- Metastatic Carcinoma in the Adrenal Cortex
- +3 more
- Laboratory Biomarker Analysis
- Nivolumab
-
Chicago, Illinois
- +1 more
Apr 11, 2019
Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,
Withdrawn
- Functional Pancreatic Neuroendocrine Tumor
- +28 more
- Capecitabine
- +4 more
- (no location specified)
Sep 26, 2017